» Articles » PMID: 1985611

Decreased Mortality in Users of Estrogen Replacement Therapy

Overview
Journal Arch Intern Med
Specialty General Medicine
Date 1991 Jan 1
PMID 1985611
Citations 71
Authors
Affiliations
Soon will be listed here.
Abstract

In a prospective study of 8881 postmenopausal female residents of a retirement community in southern California, we evaluated in detail the relationship between estrogen use and overall mortality. After 7 1/2 years of follow-up, there had been 1447 deaths. Women with a history of estrogen use had 20% lower age-adjusted, all-cause mortality than lifetime nonusers (95% confidence interval, 0.70 to 0.87). Mortality decreased with increasing duration of use and was lower among current users than among women who used estrogens only in the distant past. Current users with more than 15 years of estrogen use had a 40% reduction in their overall mortality. Among oral estrogen users, relative risks of death could not be distinguished by specific dosages of the oral estrogen taken for the longest time. Women who had used estrogen replacement therapy had a reduced mortality from all categories of acute and chronic arteriosclerotic disease and cerebrovascular disease. This group of women had a reduced mortality from cancer, although this reduction was not statistically significant. The mortality from all remaining causes combined was the same in estrogen users and lifetime nonusers.

Citing Articles

Research progress on FSH-FSHR signaling in the pathogenesis of non-reproductive diseases.

Li C, Ling Y, Kuang H Front Cell Dev Biol. 2024; 12:1506450.

PMID: 39633710 PMC: 11615068. DOI: 10.3389/fcell.2024.1506450.


Association between prescription drugs and all-cause mortality risk in the UK population.

Morin J, Rolland Y, Bischoff-Ferrari H, Ocampo A, Perez K Aging Cell. 2024; 23(12):e14334.

PMID: 39364726 PMC: 11634711. DOI: 10.1111/acel.14334.


Hormone Therapy and Biological Aging in Postmenopausal Women.

Liu Y, Li C JAMA Netw Open. 2024; 7(8):e2430839.

PMID: 39207753 PMC: 11362863. DOI: 10.1001/jamanetworkopen.2024.30839.


The association of breast cancer patients survival and prior menopausal hormone therapy in women with type 2 diabetes.

Hosio M, Urpilainen E, Hautakoski A, Arffman M, Sund R, Ahtikoski A Sci Rep. 2024; 14(1):16478.

PMID: 39013999 PMC: 11252321. DOI: 10.1038/s41598-024-65916-2.


The risk of long-term cardiometabolic disease in women with premature or early menopause: A systematic review and meta-analysis.

Liu J, Jin X, Liu W, Chen W, Wang L, Feng Z Front Cardiovasc Med. 2023; 10:1131251.

PMID: 37025693 PMC: 10072266. DOI: 10.3389/fcvm.2023.1131251.